Alnylam Pharmaceuticals (ALNY) stock forecast for 2025. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Alnylam Pharmaceuticals (ALNY) stock forecast for 2025

Updated: March 26, 2024 (06:32)

Sector: Healthcare

The share price of Alnylam Pharmaceuticals, Inc. (ALNY) now

What analysts predict: $222.59
52-week High/Low: $218.88 / $143.52

50/200 Day Moving Average: $164.18 / $178.3

This figure corresponds to the Average Price over the previous 50/200 days. For Alnylam Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Alnylam Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2025. How much will one Alnylam Pharmaceuticals share be worth in 2025? Is it worth taking profit / loss on ALNY stock now or waiting? What are analysts' forecasts for Alnylam Pharmaceuticals stock?

We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on ALNY stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Alnylam Pharmaceuticals, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Alnylam Pharmaceuticals analysts is $222.59. Today 200 Day Moving Average is the resistance level (178.3 $). 50 Day Moving Average is the resistance level (164.18 $).




Historical and forecast chart of Alnylam Pharmaceuticals, Inc. stock

The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ALNY stock price can be found in the table below.


Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.

Alnylam Pharmaceuticals (ALNY) Forecast for 2025

Month Target Pes. Opt. Vol., %
Jan 235.94 216.47 244.24 11.37 %
Feb 248.91 240.97 263.15 8.43 %
Mar 229.47 222.91 245.12 9.06 %
Apr 220.64 202.68 235.44 13.92 %
May 232.29 215.94 248.64 13.15 %
Jun 241.23 223.45 251.31 11.09 %
Jul 244.42 229.63 261.62 12.23 %
Aug 236.62 225.95 249.89 9.58 %
Sep 259.78 246.35 275.50 10.58 %
Oct 279.50 261.05 291.18 10.35 %
Nov 274.58 264.92 283.34 6.50 %
Dec 265.22 252.97 282.14 10.34 %

Alnylam Pharmaceuticals information and performance

Alnylam Pharmaceuticals Address

675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 18 813 815 000 $

Market capitalization of the Alnylam Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALNY shares in the company outstanding by the market price of one share.

EBITDA: -228 120 992 $

EBITDA of Alnylam Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.49

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.52

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.312
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 9.47

Enterprise Value (EV) /Revenue

EV To EBITDA: -80.45

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 125946000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Alnylam Pharmaceuticals price target for 2025 by month


Target values for the price of one Alnylam Pharmaceuticals share for Jan 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Jan 2025 is: 235.94.
In Jan, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 11.370% volatility is expected.
Pessimistic target level: 216.47
Optimistic target level: 244.24

Target values for the price of one Alnylam Pharmaceuticals share for Feb 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Feb 2025 is: 248.91.
In Feb, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 8.428% volatility is expected.
Pessimistic target level: 240.97
Optimistic target level: 263.15

Target values for the price of one Alnylam Pharmaceuticals share for Mar 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Mar 2025 is: 229.47.
In Mar, the Negative dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 9.062% volatility is expected.
Pessimistic target level: 222.91
Optimistic target level: 245.12

Target values for the price of one Alnylam Pharmaceuticals share for Apr 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Apr 2025 is: 220.64.
In Apr, the Negative dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 13.916% volatility is expected.
Pessimistic target level: 202.68
Optimistic target level: 235.44

Target values for the price of one Alnylam Pharmaceuticals share for May 2025.

The weighted average target price per Alnylam Pharmaceuticals share in May 2025 is: 232.29.
In May, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 13.154% volatility is expected.
Pessimistic target level: 215.94
Optimistic target level: 248.64

Target values for the price of one Alnylam Pharmaceuticals share for Jun 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Jun 2025 is: 241.23.
In Jun, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 11.087% volatility is expected.
Pessimistic target level: 223.45
Optimistic target level: 251.31

Target values for the price of one Alnylam Pharmaceuticals share for Jul 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Jul 2025 is: 244.42.
In Jul, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 12.229% volatility is expected.
Pessimistic target level: 229.63
Optimistic target level: 261.62

Target values for the price of one Alnylam Pharmaceuticals share for Aug 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Aug 2025 is: 236.62.
In Aug, the Negative dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 9.583% volatility is expected.
Pessimistic target level: 225.95
Optimistic target level: 249.89

Target values for the price of one Alnylam Pharmaceuticals share for Sep 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Sep 2025 is: 259.78.
In Sep, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 10.580% volatility is expected.
Pessimistic target level: 246.35
Optimistic target level: 275.50

Target values for the price of one Alnylam Pharmaceuticals share for Oct 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Oct 2025 is: 279.50.
In Oct, the Positive dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 10.347% volatility is expected.
Pessimistic target level: 261.05
Optimistic target level: 291.18

Target values for the price of one Alnylam Pharmaceuticals share for Nov 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Nov 2025 is: 274.58.
In Nov, the Negative dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 6.503% volatility is expected.
Pessimistic target level: 264.92
Optimistic target level: 283.34

Target values for the price of one Alnylam Pharmaceuticals share for Dec 2025.

The weighted average target price per Alnylam Pharmaceuticals share in Dec 2025 is: 265.22.
In Dec, the Negative dynamics for Alnylam Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 10.340% volatility is expected.
Pessimistic target level: 252.97
Optimistic target level: 282.14



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.